查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566928

可吸收纖維蛋白膠貼片市場：按應用、最終用戶分類：2024-2033 年全球機會分析與產業預測

Absorbable Fibrin Sealant Patch Market By Application , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 228 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

可吸收纖維蛋白膠貼片市場

2023年可吸收纖維蛋白膠貼片市值為3億美元，預計2024年至2033年複合年成長率為7.8%，到2033年將達7億美元。

可吸收纖維蛋白膠貼片是外科手術中用於控制出血和促進組織癒合的無菌物品。可吸收纖維蛋白膠貼片是一種生物分解性的貼片，由馬膠原蛋白海綿、纖維蛋白原和凝血酶組成。隨著時間的推移，貼片配方會被人體吸收，無需將其去除並降低感染疾病風險。密封劑貼片通常用於傳統縫合或縫合難以或不足以止血的手術。

由於心血管、整形外科和一般健康併發症的盛行率不斷增加，世界各地外科手術的效果不斷提高，這是可吸收纖維蛋白膠貼片市場的主要促進因素。此外，微創手術的普及正在推動密封劑貼片的採用，因為它們可以消除康復後的併發症。作為一種新興趨勢，密封劑貼片在兩側同樣活躍和有效，並且越來越受歡迎。據報道，與傳統補片相比，新型密封劑補片可在 30 分鐘內止血，平均快速六倍。

然而，與傳統手術相比，使用密封劑貼片進行的外科手術成本相當高，這就是為什麼有些人不喜歡密封劑貼片的原因。這是可吸收纖維蛋白膠貼片市場的主要限制因素。相反，密封劑補片的不斷進步預計將為市場擴張提供有利可圖的機會。根據英國科學雜誌《自然》發表的研究預測，下一代貼片正在設計中，可提供即時黏附，與快速光投射相容，並具有提供治療​​的潛力。

板塊回顧

可吸收纖維蛋白膠貼片市場按應用、最終用戶和地區細分。依應用範圍分為一般外科、心血管外科、傷口處理、整形外科、泌尿系統、眼科等。依最終使用者分類，可分為醫院和診所、門診手術中心等。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲地區。

主要發現

從應用來看，另一個細分市場主導吸收性纖維蛋白膠貼片市場。

從最終用戶來看，醫院和診所佔有很高的佔有率。

按地區分類，預計到 2033 年，北美地區的收益將最高。

該報告可以客製化。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 主要參與者的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章可吸收纖維蛋白膠貼片市場：依應用分類

  • 市場概況
  • 一般外科
  • 心血管外科
  • 傷口處理
  • 整形外科
  • 泌尿系統
  • 眼科手術
  • 其他

第5章可吸收纖維蛋白膠貼片市場：依最終用戶分類

  • 市場概況
  • 醫院和診所
  • 門診手術中心
  • 其他

第6章可吸收纖維蛋白膠貼片市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國可吸收纖維蛋白膠貼片市場
    • 加拿大可吸收纖維蛋白膠貼片市場
    • 墨西哥吸收性纖維蛋白膠貼片市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國可吸收纖維蛋白膠貼片市場
    • 法國可吸收纖維蛋白膠貼片市場
    • 英國可吸收纖維蛋白膠貼片市場
    • 義大利可吸收纖維蛋白膠貼片市場
    • 西班牙可吸收纖維蛋白膠貼片市場
    • 其他歐洲國家吸收性纖維蛋白膠貼片市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本可吸收纖維蛋白膠市場
    • 中國吸收性纖維蛋白膠貼片市場
    • 印度可吸收纖維蛋白膠貼片市場
    • 澳洲可吸收纖維蛋白膠貼片市場
    • 韓國吸收性纖維蛋白膠貼片市場
    • 其他亞太地區吸收性纖維蛋白膠貼片市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西可吸收纖維蛋白膠貼片市場
    • 沙烏地阿拉伯可吸收纖維蛋白膠貼片市場
    • 南非可吸收纖維蛋白膠貼片市場
    • 其他拉丁美洲/中東/非洲吸收性纖維蛋白膠貼片市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第8章 公司簡介

  • Johnson And Johnson
  • Baxter International Inc
  • Takeda Pharmaceutical Company Limited
  • Becton, Dickinson And Company.
  • Corza Medical
  • LifeBond Ltd
  • Surgical Specialties Corporation
  • Biegler GmbH
  • Cohera Medical Inc
  • Integra LifeSciences Corporation
簡介目錄
Product Code: A323960

Absorbable Fibrin Sealant Patch Market

The absorbable fibrin sealant patch market was valued at $0.3 billion in 2023 and is projected to reach $0.7 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

An absorbable fibrin sealant patch is a sterile object used in surgical procedures to control bleeding and promote tissue healing. It is a biodegradable patch comprising of equine collagen sponge along with fibrinogen and thrombin, elements which are the key players in the natural blood clotting mechanism of the body. The formulation of the patch involves absorption by the body over time, hence eradicating the need for removal and reducing the risk of infections. The sealant patch is significantly administered during surgeries in which conventional stapling or suturing is difficult or insufficient for hemostasis.

Rise in the conduction of surgical procedures across the globe due to increase in prevalence of cardiovascular, orthopedic, and general health complications is a key driver of the absorbable fibrin sealant patch market. Moreover, surge in the popularity of minimally invasive operations is boosting the adoption of sealant patches as they eliminate the post-recovery intricacies. As an emerging trend, sealant patches that are equally active and effective on both sides are acquiring traction. When compared to the conventional patches, the new sealant patches are reported to be quick by an average of six times, ceasing bleeding in 30 minutes.

However, the cost of surgical procedures involving the use of sealant patches is significantly high as compared to the traditional surgeries, which deters several individuals from preferring them. This acts a major restraint for the absorbable fibrin sealant patch market. On the contrary, constant advancements in sealant patches are expected to present lucrative opportunities for market expansion. According to a study published in Nature, a British scientific journal, next generation of patches are being designed that are projected to provide instant adhesion, possess compatibility with rapid photo-projection, and have the potential to deliver therapeutics.

Segment Review

The absorbable fibrin sealant patch market is segmented into application, end user, and region. On the basis of application, the market is divided into general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, and others. As per end user, it is classified into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of application, the others segment dominates the absorbable fibrin sealant patch market.

As per end user, the hospitals & clinics segment holds a high share of the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global absorbable fibrin sealant patch market include Johnson & Johnson, Baxter International Inc, Takeda Pharmaceutical Company Limited, Becton, Dickinson and Company, Corza Medical, LifeBond Ltd, Surgical Specialties Corporation, Biegler GmbH, Cohera Medical Inc, and Integra LifeSciences Corporation. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Application

  • General Surgery
  • Cardiovascular Surgery
  • Wound Management
  • Orthopedic Surgery
  • Urological Surgery
  • Ophthalmic Surgery
  • Others

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Johnson & Johnson
    • Baxter International Inc
    • Takeda Pharmaceutical Company Limited
    • Becton, Dickinson and Company.
    • Corza Medical
    • LifeBond Ltd
    • Surgical Specialties Corporation
    • Biegler GmbH
    • Cohera Medical Inc
    • Integra LifeSciences Corporation

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Application
  • 4.2. General Surgery
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Cardiovascular Surgery
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Wound Management
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Orthopedic Surgery
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Urological Surgery
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country
  • 4.7. Ophthalmic Surgery
    • 4.7.1. Key Market Trends, Growth Factors and Opportunities
    • 4.7.2. Market Size and Forecast, By Region
    • 4.7.3. Market Share Analysis, By Country
  • 4.8. Others
    • 4.8.1. Key Market Trends, Growth Factors and Opportunities
    • 4.8.2. Market Size and Forecast, By Region
    • 4.8.3. Market Share Analysis, By Country

CHAPTER 5: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals And Clinics
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ambulatory Surgical Centers
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Application
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Absorbable Fibrin Sealant Patch Market
      • 6.2.5.1. Market Size and Forecast, By Application
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Absorbable Fibrin Sealant Patch Market
      • 6.2.6.1. Market Size and Forecast, By Application
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Absorbable Fibrin Sealant Patch Market
      • 6.2.7.1. Market Size and Forecast, By Application
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Application
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Absorbable Fibrin Sealant Patch Market
      • 6.3.5.1. Market Size and Forecast, By Application
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Absorbable Fibrin Sealant Patch Market
      • 6.3.6.1. Market Size and Forecast, By Application
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Absorbable Fibrin Sealant Patch Market
      • 6.3.7.1. Market Size and Forecast, By Application
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Absorbable Fibrin Sealant Patch Market
      • 6.3.8.1. Market Size and Forecast, By Application
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Absorbable Fibrin Sealant Patch Market
      • 6.3.9.1. Market Size and Forecast, By Application
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Absorbable Fibrin Sealant Patch Market
      • 6.3.10.1. Market Size and Forecast, By Application
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Application
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Absorbable Fibrin Sealant Patch Market
      • 6.4.5.1. Market Size and Forecast, By Application
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Absorbable Fibrin Sealant Patch Market
      • 6.4.6.1. Market Size and Forecast, By Application
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Absorbable Fibrin Sealant Patch Market
      • 6.4.7.1. Market Size and Forecast, By Application
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. Australia Absorbable Fibrin Sealant Patch Market
      • 6.4.8.1. Market Size and Forecast, By Application
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Absorbable Fibrin Sealant Patch Market
      • 6.4.9.1. Market Size and Forecast, By Application
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Absorbable Fibrin Sealant Patch Market
      • 6.4.10.1. Market Size and Forecast, By Application
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Application
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Absorbable Fibrin Sealant Patch Market
      • 6.5.5.1. Market Size and Forecast, By Application
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Absorbable Fibrin Sealant Patch Market
      • 6.5.6.1. Market Size and Forecast, By Application
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Absorbable Fibrin Sealant Patch Market
      • 6.5.7.1. Market Size and Forecast, By Application
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Absorbable Fibrin Sealant Patch Market
      • 6.5.8.1. Market Size and Forecast, By Application
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Johnson And Johnson
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Baxter International Inc
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Takeda Pharmaceutical Company Limited
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Becton, Dickinson And Company.
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Corza Medical
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. LifeBond Ltd
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Surgical Specialties Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Biegler GmbH
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Cohera Medical Inc
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Integra LifeSciences Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments